118 related articles for article (PubMed ID: 2557379)
1. Biological response modifier enhances the activity of natural killer cell against human cytomegalovirus-infected cells.
Murayama T; Natsuume-Sakai S; Xu B; Furukawa T; Rinaldo CR
J Med Virol; 1989 Oct; 29(2):102-8. PubMed ID: 2557379
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes.
Gehrz RC; Rutzick SR
Clin Exp Immunol; 1985 Jul; 61(1):80-9. PubMed ID: 2994924
[TBL] [Abstract][Full Text] [Related]
3. Human T helper cells specific for antigens of typhus group rickettsiae enhance natural killer cell activity in vitro.
Carl M; Martin EE; Dasch GA
Infect Immun; 1986 Nov; 54(2):297-302. PubMed ID: 2945787
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
Bonavida B; Katz J; Hoshino T
Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
[TBL] [Abstract][Full Text] [Related]
5. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
Huang XL; Fan Z; Murayama T; Rinaldo C
Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.
Rook AH; Masur H; Lane HC; Frederick W; Kasahara T; Macher AM; Djeu JY; Manischewitz JF; Jackson L; Fauci AS; Quinnan GV
J Clin Invest; 1983 Jul; 72(1):398-403. PubMed ID: 6308051
[TBL] [Abstract][Full Text] [Related]
8. Natural killing (NK) of cytomegalovirus (CMV)-infected fibroblasts: a comparison between two strains of CMV, uninfected fibroblasts, and K562 cells.
Waner JL; Nierenberg JA
J Med Virol; 1985 Jul; 16(3):233-44. PubMed ID: 2993494
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
[TBL] [Abstract][Full Text] [Related]
10. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
[TBL] [Abstract][Full Text] [Related]
11. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.
Newhook N; Fudge N; Grant M
Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279
[TBL] [Abstract][Full Text] [Related]
12. Lysis of human arterial smooth muscle cells infected with herpesviridae by peripheral blood mononuclear cells: implications for atherosclerosis.
Datta SK; Tumilowicz JJ; Trentin JJ
Viral Immunol; 1993; 6(2):153-60. PubMed ID: 8216714
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
[TBL] [Abstract][Full Text] [Related]
14. Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation.
Bowden RA; Day LM; Amos DE; Meyers JD
Transplantation; 1987 Oct; 44(4):504-8. PubMed ID: 2823422
[TBL] [Abstract][Full Text] [Related]
15. Reduction by OK-432 of the monolayer contact-mediated inhibition of human natural killer cell activity.
Yagita M; Saksela E
Immunol Lett; 1990 Sep; 25(4):347-53. PubMed ID: 2249878
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.
Nio Y; Zighelboim J; Berek JS; Bonavida B
Nat Immun Cell Growth Regul; 1990; 9(4):283-96. PubMed ID: 2215516
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR-restricted cytotoxicity of cytomegalovirus-infected monocytes mediated by Leu-3-positive T cells.
Lindsley MD; Torpey DJ; Rinaldo CR
J Immunol; 1986 Apr; 136(8):3045-51. PubMed ID: 2420881
[TBL] [Abstract][Full Text] [Related]
18. Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.
Bandyopadhyay S; Perussia B; Trinchieri G; Miller DS; Starr SE
J Exp Med; 1986 Jul; 164(1):180-95. PubMed ID: 3014033
[TBL] [Abstract][Full Text] [Related]
19. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
